-
Product Insights
NYC ECF – 489 State Street Educational Building – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our NYC ECF - 489 State Street Educational Building - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
NYC ECF – 80 Flatbush Mixed-Use Development – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our NYC ECF - 80 Flatbush Mixed-Use Development - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Toll Like Receptor 4 (hToll or CD284 or TLR4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Toll Like Receptor 4 (TLR4) Drugs in Development Report Overview Toll-like receptor 4 is a protein encoded by the TLR4 gene. The Toll Like Receptor 4 (hToll or CD284 or TLR4) drugs in development research report provides comprehensive information on the therapeutics under development for toll like receptor 4. The report also analyzes the stage of development, mechanism of action (MoA), route of administration (RoA), molecule type, therapy area, and indication. The pipeline report covers the descriptive pharmacological action and...
-
Sector Analysis
Dry Eye Syndrome: Global Drug Forecast and Market Analysis to 2026
Dry Eye Syndrome (DES) is a multifactorial disease of the tears and ocular surface that causes ocular discomfort, visual disturbances, and tear film instability, which can potentially damage the ocular surface. With a rapidly accelerating worldwide prevalence and the limited treatment options available, there is a growing pressure for new therapies and curative treatment for DES patients. Significant efforts are being made to develop a new treatment for DES, as current pharmacologic management is known to only provide temporary symptomatic...
-
Product Insights
Cystinosis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Cystinosis Global Clinical Trials Review, H2, 2018" provides an overview of Cystinosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystinosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...